105.16
+0.52(+0.50%)
Currency In USD
| Previous Close | 104.64 |
| Open | 104.53 |
| Day High | 105.55 |
| Day Low | 102.55 |
| 52-Week High | 139.13 |
| 52-Week Low | 64.11 |
| Volume | 481,435 |
| Average Volume | 694,546 |
| Market Cap | 5.18B |
| PE | -18.23 |
| EPS | -5.77 |
| Moving Average 50 Days | 108.6 |
| Moving Average 200 Days | 101.21 |
| Change | 0.52 |
If you invested $1000 in Axsome Therapeutics, Inc. (AXSM) since IPO date, it would be worth $12,032.04 as of June 01, 2025 at a share price of $105.16. Whereas If you bought $1000 worth of Axsome Therapeutics, Inc. (AXSM) shares 5 years ago, it would be worth $1,365.89 as of June 01, 2025 at a share price of $105.16.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Axsome Therapeutics Presents Data from Three of Its Innovative Neuroscience Programs at the American Society of Clinical Psychopharmacology (ASCP) 2025 Annual Meeting
GlobeNewswire Inc.
May 28, 2025 11:00 AM GMT
NEW YORK, May 28, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced presentations from three of its innovativ
Axsome Therapeutics Settles SUNOSI® (solriamfetol) Patent Litigation with Hetero Labs Ltd.
GlobeNewswire Inc.
May 27, 2025 11:00 AM GMT
NEW YORK, May 27, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM) (Axsome), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced that it has entered into a settl
Axsome Therapeutics Enters $570 Million Term Loan and Revolving Credit Facility with Blackstone
GlobeNewswire Inc.
May 13, 2025 11:00 AM GMT
Previous term loan facility retired NEW YORK, May 13, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced that